News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
655,415 Results
Type
Article (49067)
Company Profile (252)
Press Release (606096)
Section
Business (189602)
Career Advice (2650)
Deals (34319)
Drug Delivery (117)
Drug Development (81550)
Employer Resources (162)
FDA (16678)
Job Trends (14205)
News (331424)
Policy (33711)
Tag
Academia (2519)
Alliances (47124)
Alzheimer's disease (1377)
Approvals (16613)
Artificial intelligence (178)
Bankruptcy (334)
Best Places to Work (10615)
Biotechnology (133)
Breast cancer (209)
Cancer (1576)
Cardiovascular disease (130)
Career advice (2204)
CAR-T (116)
Cell therapy (333)
Clinical research (65405)
Collaboration (571)
Compensation (313)
COVID-19 (2665)
C-suite (139)
Data (1458)
Diabetes (200)
Diagnostics (5788)
Earnings (74878)
Employer resources (147)
Events (99079)
Executive appointments (482)
FDA (17471)
Funding (498)
Gene therapy (233)
GLP-1 (726)
Government (4187)
Healthcare (17082)
Infectious disease (2768)
Inflammatory bowel disease (120)
Interviews (477)
IPO (15893)
Job creations (4003)
Job search strategy (1857)
Layoffs (478)
Legal (8250)
Lung cancer (235)
Manufacturing (234)
Medical device (12259)
Medtech (12263)
Mergers & acquisitions (18690)
Metabolic disorders (563)
Neuroscience (1767)
NextGen: Class of 2025 (5863)
Non-profit (3721)
Northern California (1819)
Obesity (327)
Opinion (242)
Parkinson's disease (110)
Patents (139)
People (55309)
Phase I (20103)
Phase II (28442)
Phase III (22020)
Pipeline (634)
Postmarket research (2805)
Preclinical (8294)
Radiopharmaceuticals (242)
Rare diseases (306)
Real estate (5741)
Regulatory (22958)
Research institute (2316)
Resumes & cover letters (439)
Southern California (1551)
Startups (3468)
United States (16159)
Vaccines (668)
Weight loss (253)
Date
Today (138)
Last 7 days (408)
Last 30 days (1964)
Last 365 days (34579)
2025 (1746)
2024 (34961)
2023 (39133)
2022 (50081)
2021 (54091)
2020 (51696)
2019 (42876)
2018 (32750)
2017 (32517)
2016 (31563)
2015 (35660)
2014 (29174)
2013 (24460)
2012 (26480)
2011 (27240)
2010 (25334)
Location
Africa (808)
Arizona (174)
Asia (40809)
Australia (6542)
California (4088)
Canada (1450)
China (366)
Colorado (187)
Connecticut (219)
Europe (91906)
Florida (588)
Georgia (145)
Illinois (385)
Indiana (236)
Maryland (685)
Massachusetts (3255)
Michigan (159)
Minnesota (287)
New Jersey (1178)
New York (1155)
North Carolina (822)
Northern California (1819)
Ohio (138)
Pennsylvania (945)
South America (1203)
Southern California (1551)
Texas (597)
Washington State (416)
655,415 Results for "covis pharma holdings s a r l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Accelerated approval
Inspector General Questions FDA’s Accelerated Approval for Biogen, Sarepta Drugs
An OIG report zeroed in on what it said were three particularly problematic accelerated approvals: Biogen’s Aduhelm, Sarepta’s Exondys and Covis’ Makena.
January 15, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Deals
Two Private Equity Firms Near Potential $3B+ Deal for Mitsubishi’s Pharma Unit: Reuters
Blackstone and Bain Capital are said to be among the final bidders for the Japanese company’s Mitsubishi Tanabe Pharma, sources told Reuters Friday.
December 13, 2024
·
1 min read
·
Annalee Armstrong
Deals
Frontage Laboratories Acquires Accelera S.r.l.'s Bioanalytical and DMPK Businesses
Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
January 2, 2024
·
5 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering
January 16, 2025
·
5 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
January 14, 2025
·
5 min read
Press Releases
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity
January 8, 2025
·
2 min read
Business
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
August 26, 2024
·
5 min read
1 of 65,542
Next
